You are here: Industry Insights > Vaccine

News List

Radiance could be the key to faster viral detection europeanpharmaceuticalreview
April 18, 2019
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection…
Vaccine facility targets development and manufacturing to fight pandemics europeanpharmaceuticalreview
April 18, 2019
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines...
Further advances in cell-based influenza vaccine technology announced firstwordpharma
April 18, 2019
An influenza vaccine manufacturer has announced it is filing an Annual Strain Update with the US Food and Drug Administration (FDA) in the coming weeks due to advances in influenza vaccine technology.
Researchers develop new vaccine to teach immune system to attack cancer pharmaceutical-technology
April 11, 2019
Researchers develop new vaccine to teach immune system to attack cancer.
New glioblastoma cancer vaccine shows promise in phase 1b clinical trial europeanpharmaceuticalreview
April 02, 2019
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial…
VGXI Achieves Tech Transfer Milestones contractpharma
March 20, 2019
Relates to RNA manufacturing partnership with research inst. in Houston
Computer-designed vaccine elicits potent antibodies against RSV worldpharmanews
March 11, 2019
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus (RSV) has been designed in an international research effort.
Children’s vaccine 87% effective against circulating flu strain firstwordpharma
February 24, 2019
Public Health England (PHE) has published mid-season data on the effectiveness of this year’s flu vaccines, alongside data from other countries, in Eurosurveillance. The data suggest that the nasal spray flu vaccine is 87% effective in children aged 2 to
United Neuroscience inches closer to Alzheimer’s vaccine prize pharmaphorum
January 22, 2019
A vaccine for Alzheimer’s disease developed by United Neuroscience has cleared a phase IIa trial, and seems to be free of the toxicity that has scuppered earlier candidates.
MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS) b3cnewswire
January 22, 2019
MinervaX, a privately held Danish biotech company, announces today that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to ....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page